Clinical Trials Directory

Trials / Completed

CompletedNCT06691568

Effectiveness of an Air Purifier on Asthmatic and Cat-allergic Subjects in the ALYATEC Environmental Exposure Chamber

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Dyson Technology Ltd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate the efficacy of air purifiers in reducing allergy symptoms in patients with a cat allergy. The main question it aims to answer is: If there is a reduction of early asthmatic response (EAR) compared to placebo. Participants were asked to remain in an exposure chamber for 2 hours while their symptoms were monitored.

Detailed description

For this protocol, 30 patients with cat allergies were exposed to 80ng/m3 of Fel d 1 allergen in the ALYATEC Environmental Exposure Chamber (EEC). The active group of 15 had Dyson BP06 air purifiers running at speed 2, while the placebo group had the purifiers on, but not circulating air (speed 0). Participants were monitored for the primary objective of reduction of EAR, alongside other secondary objectives: 1. To evaluate the efficacy of air purifier on time to induce EAR during a 2-hour cat allergen exposure in ALYATEC EEC compared to placebo 2. To evaluate the efficacy of air purifier on allergic rhino-conjunctivitis symptoms during a 2-hour cat allergen exposure in ALYATEC EEC compared to a placebo 3. To evaluate the efficacy of air purifier on bronchial response severity during a 2-hour cat allergen exposure in ALYATEC EEC compared to placebo. 4. To evaluate the rescue treatments used after 2-hour cat allergen exposure with the air purifier compared to placebo 5. To evaluate the efficacy of air purifier on allergic rhinitis symptoms during a 2-hour cat allergen exposure in ALYATEC EEC compared to a placebo

Conditions

Interventions

TypeNameDescription
DEVICEAir purifierPurifiers were turned on for the active group and off for the placebo

Timeline

Start date
2023-01-20
Primary completion
2023-10-26
Completion
2023-10-26
First posted
2024-11-15
Last updated
2024-11-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06691568. Inclusion in this directory is not an endorsement.